Institutional Fund
Deerfield Management Company, L.P.
New York, NYCIK 10092585 filings on record
Portfolio Value
$7.18B
Q1 2026
Holdings
73
Reported positions
New Buys
10
Opened this quarter
QoQ Change
+4.9%
from $6.84B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Nuvalent Inc24.6%
- Cogent Biosciences Inc4.9%
- Praxis Precision Medicines I4.3%
- Viatris Inc3.8%
- United Therapeutics Corp Del3.8%
- Revolution Medicines Inc3.1%
- Other55.5%
Portfolio Holdings
73 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Nuvalent Inc | 17.25M | $1.77B | 24.6% | 0 | Held |
| 2 | Cogent Biosciences Inc | 9.04M | $348.10M | 4.9% | 0 | Held |
| 3 | Praxis Precision Medicines I | 963.4K | $310.38M | 4.3% | +60.0K | Added |
| 4 | Viatris Inc | 20.21M | $272.99M | 3.8% | 0 | Held |
| 5 | United Therapeutics Corp Del | 457.0K | $270.99M | 3.8% | +31.0K | Added |
| 6 | Revolution Medicines Inc | 2.30M | $223.38M | 3.1% | −597.6K | Reduced |
| 7 | Celcuity Inc | 1.71M | $195.64M | 2.7% | 0 | Held |
| 8 | Centene Corp Del | 5.92M | $193.73M | 2.7% | −530.9K | Reduced |
| 9 | Larimar Therapeutics Inc | 35.61M | $160.23M | 2.2% | +5.00M | Added |
| 10 | Brookdale Sr Living Inc | 11.64M | $159.19M | 2.2% | 0 | Held |
63 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio